Stellar Biotechnologies (SBOT) Is At $1.24 Formed Wedge; Mazor Robotics Limited Ads (MZOR) Shorts Up By 2.39%

May 25, 2017 - By Peter Erickson

Stellar Biotechnologies Inc (SBOT) formed wedge down with $1.19 target or 4.00% below today’s $1.24 share price. Stellar Biotechnologies Inc (SBOT) has $12.58 million valuation. The stock decreased 0.80% or $0.01 on May 24, reaching $1.24. About shares traded. Stellar Biotechnologies Inc (NASDAQ:SBOT) has declined 60.19% since May 25, 2016 and is downtrending. It has underperformed by 76.89% the S&P500.

Mazor Robotics Limited Ads (NASDAQ:MZOR) had an increase of 2.39% in short interest. MZOR’s SI was 2.05 million shares in May as released by FINRA. Its up 2.39% from 2.01 million shares previously. With 656,500 avg volume, 3 days are for Mazor Robotics Limited Ads (NASDAQ:MZOR)’s short sellers to cover MZOR’s short positions. The SI to Mazor Robotics Limited Ads’s float is 11.73%. The stock decreased 0.70% or $0.28 during the last trading session, reaching $39.74. About 250 shares traded. Mazor Robotics Ltd – ADR (NASDAQ:MZOR) has risen 206.35% since May 25, 2016 and is uptrending. It has outperformed by 189.65% the S&P500.

Mazor Robotics Ltd is an Israel-based medical device firm that develops and markets surgical guidance systems and complementary products. The company has market cap of $938.06 million. It develops computerized and imaging systems in the field of spine surgery. It currently has negative earnings. The Company’s products include: Renaissance Surgical Guidance System, which enables surgeons to advance from freehand surgical procedures to guided procedures, as well as Food and Drug Administration -cleared and European Conformity (CE)-marked Renaissance System, used in spine surgeries, whether open or minimally invasive, for a number of clinical indications.

Among 5 analysts covering Mazor Robotics (NASDAQ:MZOR), 2 have Buy rating, 1 Sell and 2 Hold. Therefore 40% are positive. Mazor Robotics had 8 analyst reports since November 20, 2015 according to SRatingsIntel. Barclays Capital maintained the stock with “Overweight” rating in Thursday, July 14 report. The firm has “Outperform” rating by Wells Fargo given on Thursday, May 19. B. Riley & Co initiated Mazor Robotics Ltd – ADR (NASDAQ:MZOR) rating on Friday, October 7. B. Riley & Co has “Buy” rating and $25 target. The firm has “Reduce” rating by Standpoint Research given on Wednesday, April 19. Sterne Agee CRT upgraded the stock to “Buy” rating in Friday, November 20 report. The stock of Mazor Robotics Ltd – ADR (NASDAQ:MZOR) earned “Neutral” rating by Sterne Agee CRT on Tuesday, May 31. The company was initiated on Friday, July 8 by Standpoint Research. The company was downgraded on Thursday, May 11 by Wells Fargo.